Magellan Biosciences Inc. tapped Hiroshi Uchida, the former technology chief for Fenwal Inc., to be its new president and CEO.
The Chelmsford, Mass.-based diagnostics firm said Uchida was instrumental in the carve-out of Fenwal from former parent Baxter International (NYSE:BAX) in 2007. The blood management company’s product launches and revenues grew on his watch and operating costs declined “significantly,” according to a press release.
Uchida’s resumé also includes stints at another diagnostics firm, Dade Behring Inc., management consulting company Arthur D. Little and Bain & Co., according to the presser.